Crescent Capital BDC (NASDAQ:CCAP – Free Report) had its price target boosted by Keefe, Bruyette & Woods from $19.00 to $20.00 in a research report sent to investors on Monday,Benzinga reports. They currently have an outperform rating on the stock.
Several other brokerages have also recently commented on CCAP. LADENBURG THALM/SH SH assumed coverage on shares of Crescent Capital BDC in a research report on Monday, September 30th. They set a “buy” rating and a $20.00 price target for the company. Bank of America lowered their target price on shares of Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating for the company in a report on Thursday, August 15th. Finally, Wells Fargo & Company dropped their target price on shares of Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating for the company in a research report on Wednesday, August 14th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, Crescent Capital BDC has a consensus rating of “Moderate Buy” and a consensus price target of $19.17.
Get Our Latest Stock Report on Crescent Capital BDC
Crescent Capital BDC Price Performance
Crescent Capital BDC Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Tuesday, December 31st will be paid a $0.42 dividend. This represents a $1.68 annualized dividend and a yield of 8.71%. The ex-dividend date is Tuesday, December 31st. This is an increase from Crescent Capital BDC’s previous quarterly dividend of $0.07. Crescent Capital BDC’s dividend payout ratio is presently 65.88%.
Hedge Funds Weigh In On Crescent Capital BDC
Several institutional investors and hedge funds have recently made changes to their positions in the company. Point72 Asset Management L.P. acquired a new stake in Crescent Capital BDC during the 2nd quarter worth $90,000. XTX Topco Ltd acquired a new stake in shares of Crescent Capital BDC during the second quarter worth about $195,000. Catalina Capital Group LLC acquired a new stake in shares of Crescent Capital BDC during the second quarter worth about $220,000. Cubist Systematic Strategies LLC bought a new position in shares of Crescent Capital BDC during the 2nd quarter valued at about $346,000. Finally, Van ECK Associates Corp grew its position in shares of Crescent Capital BDC by 136.1% in the 2nd quarter. Van ECK Associates Corp now owns 26,521 shares of the company’s stock valued at $498,000 after purchasing an additional 15,288 shares during the period. Institutional investors and hedge funds own 49.46% of the company’s stock.
Crescent Capital BDC Company Profile
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Further Reading
- Five stocks we like better than Crescent Capital BDC
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What is a Secondary Public Offering? What Investors Need to Know
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.